Abstract
Attention deficit hyperactivity disorder (ADHD) is classified as a neurodevelopmental disorder and has a prevalence of between 2% and 7%, depending on the stage of life. It presents in childhood and persists into adulthood in up to half of cases, representing a developmental risk factor. It is practically a constant comorbidity with other psychiatric disorders, the most frequent of which are behavioral and learning disorders in childhood; in adulthood, the most prevalent comorbidities are mood and emotional disorders. Treatment must be based on an adequate diagnosis that goes beyond merely meeting the diagnostic criteria and which is accompanied by a longitudinal analysis of symptoms, their functional impact, and comorbidities. Then, the basis of the reference guidelines is multimodal treatment, combining psychoeducational, psychopharmacological, and psychotherapeutic measures in an individualized manner.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Medicine - Programa de Formación Médica Continuada acreditado
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
